Therapeutics Acquisition Corp. (RACA)

$10.2743

+0.24 (+2.44%)
Rating:
Recommendation:
-
Symbol RACA
Price $10.2743
Beta 0.000
Volume Avg. 0.14M
Market Cap 179.117M
Shares () -
52 Week Range 9.81-18.08
1y Target Est -
DCF Unlevered RACA DCF ->
DCF Levered RACA LDCF ->
ROE -49.01% Strong Sell
ROA -
Operating Margin -
Debt / Equity -
P/E -
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Dr. Peter Kolchinsky Ph.D.
Financial Services
Shell Companies
Nasdaq Capital Market

Therapeutics Acquisition Corp., doing business as Research Alliance Corp. I, intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry in the United States. The company was founded in 2020 and is based in Boston, Massachusetts.